Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
12 02 2019
Historique:
entrez: 5 3 2019
pubmed: 5 3 2019
medline: 6 2 2020
Statut: epublish

Résumé

Translation of novel discoveries to human disease is limited by the availability of human tissue-based models of disease. Precision-cut lung slices (PCLS) used as 3D lung tissue cultures (3D-LTCs) represent an elegant and biologically highly relevant 3D cell culture model, which highly resemble in situ tissue due to their complexity, biomechanics and molecular composition. Tissue slicing is widely applied in various animal models. 3D-LTCs derived from human PCLS can be used to analyze responses to novel drugs, which might further help to better understand the mechanisms and functional effects of drugs in human tissue. The preparation of PCLS from surgically resected lung tissue samples of patients, who experienced lung lobectomy, increases the accessibility of diseased and peritumoral tissue. Here, we describe a detailed protocol for the generation of human PCLS from surgically resected soft-elastic patient lung tissue. Agarose was introduced into the bronchoalveolar space of the resectates, thus preserving lung structure and increasing the tissue's stiffness, which is crucial for subsequent slicing. 500 µm thick slices were prepared from the tissue block with a vibratome. Biopsy punches taken from PCLS ensure comparable tissue sample sizes and further increase the amount of tissue samples. The generated lung tissue cultures can be applied in a variety of studies in human lung biology, including the pathophysiology and mechanisms of different diseases, such as fibrotic processes at its best at (sub-)cellular levels. The highest benefit of the 3D-LTC ex vivo model is its close representation of the in situ human lung in respect of 3D tissue architecture, cell type diversity and lung anatomy as well as the potential for assessment of tissue from individual patients, which is relevant to further develop novel strategies for precision medicine.

Identifiants

pubmed: 30829341
doi: 10.3791/58437
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Michael Gerckens (M)

Comprehensive Pneumology Center, Ludwig-Maximilians-Universität and Helmholtz Zentrum Munich; German Center of Lung Research (DZL); Translational Lung Research and CPC-M bioArchive, Helmholtz Zentrum München, Comprehensive Pneumology Center Munich DZL/CPC-M.

Hani N Alsafadi (HN)

Department of Experimental Medical Science, Lung Bioengineering and Regeneration, Lund University; Wallenberg Center for Molecular Medicine, Lund University; Stem Cell Centre, Lund University.

Darcy E Wagner (DE)

Department of Experimental Medical Science, Lung Bioengineering and Regeneration, Lund University; Wallenberg Center for Molecular Medicine, Lund University; Stem Cell Centre, Lund University.

Michael Lindner (M)

German Center of Lung Research (DZL); Asklepios Fachkliniken Munich-Gauting.

Gerald Burgstaller (G)

Comprehensive Pneumology Center, Ludwig-Maximilians-Universität and Helmholtz Zentrum Munich; German Center of Lung Research (DZL); Translational Lung Research and CPC-M bioArchive, Helmholtz Zentrum München, Comprehensive Pneumology Center Munich DZL/CPC-M; gerald.burgstaller@helmholtz-muenchen.de.

Melanie Königshoff (M)

Comprehensive Pneumology Center, Ludwig-Maximilians-Universität and Helmholtz Zentrum Munich; German Center of Lung Research (DZL); Translational Lung Research and CPC-M bioArchive, Helmholtz Zentrum München, Comprehensive Pneumology Center Munich DZL/CPC-M; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado; melanie.koenigshoff@ucdenver.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH